PYRAZOLO[1,5A]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:F. Hoffmann-La Roche AG
公开号:EP3252054A1
公开(公告)日:2017-12-06
Compounds of the formula I or II:
wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
式 I 或 II 的化合物:
其中 X、m、Ar、R1 和 R2 如本文所定义。上述化合物可用于治疗 IRAK 介导的病症。
Leis, J. Ramon; Rios, Ana; Rodriguez-Sanchez, Luiza, Journal of the Chemical Society. Perkin transactions II, 1998, # 12, p. 2729 - 2734
作者:Leis, J. Ramon、Rios, Ana、Rodriguez-Sanchez, Luiza
DOI:——
日期:——
o-NITROSOPHENOLS. II. NEW SUBSTITUTED o-NITROSOPHENOLS AND CHARACTERISTIC PROPERTIES OF THEIR INNER COMPLEX METAL SALTS<sup>1</sup>